← Open Payments lookup

SAMUEL AMPONSAH: Open Payments

NPI 1285394262 · ABERDEEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$787 in 51 payments from 10 companies in 2025. Trend: 2023 $165 · 2024 $332 · 2025 $787

Food & beverage: $787
CompanyPaymentsAmount
ABBVIE INC.18$207
E.R. Squibb & Sons, L.L.C.7$127
Janssen Pharmaceuticals, Inc5$102
Teva Pharmaceuticals USA, Inc.5$78
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$72
Otsuka America Pharmaceutical, Inc.4$65
Neurocrine BioSciences, Inc.3$61
Lundbeck LLC2$29
Alkermes, Inc.2$29
Vanda Pharmaceuticals Inc.1$16

Products named: VRAYLAR, COBENFY, REXULTI, CAPLYTA, SPRAVATO, INGREZZA, UZEDY, INVEGA SUSTENNA.

Industry payments across NJ — which companies pay providers there.